Srivalli Telikepalli
Research Chemist
Dr. Srivalli Telikepalli is a recognized expert in biopharmaceutical analytical science with more than 10 years of experience specializing in protein aggregation, particle characterization, and monoclonal antibody stability. As a Research Chemist at National Institute of Standards and Technology, she has led the development of several industry-first reference materials, including the first subvisible and visible protein-like particle standards, and supported the NIST monoclonal antibody reference material, which are now widely used across the biopharmaceutical industry for analytical benchmarking and quality control. Dr. Telikepalli currently leads major cross-industry collaborations involving global biopharmaceutical companies to advance standards for protein aggregation and visual inspection methodologies, helping shape emerging regulatory and industry best practices. An internationally invited speaker and thought leader in biologics stability and analytical characterization, she has authored numerous high-impact publications and received multiple honors from the U.S. Department of Commerce for her contributions to measurement science and biopharmaceutical standards.
DAY 2: September 29th, 2026
SESSION: Development of New Visible Particle Reference Material for Biopharmaceutical Advancement (tentative)
◆ Particle Based Reference Materials in Development.
◆ Need for Visible Particle Reference Material.
◆ Development and Applications of Visible Particle Reference Material.
